Evotec SE today announced its participation in iCARE4CVD, an international public-private research consortium iCARE4CVD (individualised care from early risk of cardiovascular disease to established heart failure) to better understand cardiovascular disease and optimise future prevention and treatment. The consortium brings together 33 leading international partners from civil society, academia and industry, and is led and coordinated by Maastricht University and global healthcare company Novo Nordisk.
↧